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Abstract
Objective To compare the healing pattern of osteoid
osteomas on computed tomography (CT) and magnetic
resonance imaging (MRI) after successful and unsuccessful
thermocoagulation.
Materials and methods Eighty-six patients were examined
by CTand 18 patients by dynamic gadolinium-enhanced MRI
before and after thermocoagulation for osteoid osteoma.
Thermocoagulation was successful in 73% (63/86) and
unsuccessful in 27% (23/86) of patients followed by CT.
Thermocoagulation was successful in 72% (13/18) of patients
followed by MRI. After treatment, the healing of the nidus on
CT was evaluated using different healing patterns (complete
ossification, minimal nidus rest, decreased size, unchanged
size or thermonecrosis). On MRI the presence of reactive
changes (joint effusion, “oedema-like” changes of bone
marrow and soft tissue oedema) and the delay time (between
arterial and nidus enhancement) were assessed and compared
before and after thermocoagulation.
Results Complete ossification or a minimal nidus rest was
observed on CT in 58% (16/28) of treatment successes
(with > 12 months follow-up), but not in treatment
failures. “Oedema-like” changes of bone marrow and/or
soft tissue oedema were seen on MR in all patients before
thermocoagulation and in all treatment failures. However,
residual “oedema-like” changes of bone marrow were also
found in 69% (9/13) of treatment successes. An increased
delay time was observed in 62% (8/13) of treatment
successes and in 1/5 of treatment failures.
Conclusion Complete, or almost complete, ossification of
the treated nidus on CT correlated with successful treat-
ment. Absence of this ossification pattern, however, did not
correlate with treatment failure. CT could not be used to
identify the activity of the nidus following treatment. The
value of MR parameters to assess residual activity of the
nidus was limited in this study.
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Introduction
Thermocoagulation is an effective and safe treatment for
osteoid osteoma [1, 2]. The typical clinical and imaging
features of osteoid osteoma on plain radiographs, bone
scintigraphy and computed tomography (CT) have been
described in detail [3–5]. The radiolucent nidus is best seen
on thin slice (1 mm to 2 mm) axial CT images, because
there is no overlap of surrounding reactive sclerosis and/or
periosteal reaction [3–5]. More recent papers have focused
on the appearance of osteoid osteoma on magnetic
resonance imaging (MRI), describing the morphology of
the nidus, the surrounding bone, and the adjacent soft
tissues, as well as the enhancement pattern of the nidus
during dynamic MRI imaging [6, 7].
The healing pattern of the nidus of osteoid osteomas has
been described by Lindner et al. [8] and Martel et al. [9].
Since these imaging features have been reviewed in only
successfully treated patients, it is unclear whether the
imaging features during follow-up correlate with the
clinical results of the thermocoagulation. The purpose of
this study was, therefore, to compare the healing pattern of
osteoid osteomas on CT and MRI in patients after
successful and unsuccessful thermocoagulation.
Materials and methods
Patients
The records of 110 consecutive patients diagnosed with
osteoid osteoma and treated with thermocoagulation be-
tween June 1994 and April 2000 were retrieved from our
database. All patients gave informed consent for imaging
studies and treatment. Our local institutional review board
does not require informed consent for retrospective analysis
of clinical data. Thirteen patients were excluded from this
analysis because of incomplete follow-up data. Four of
these 13 patients were excluded because of incomplete
follow-up data, and nine of 13 patients were excluded
because of a short (fewer than 3 months) but symptom-free
follow-up. In the nine patients with fewer than 3 months’
follow-up, no further follow-up data after 3 months were
available. Of these 110 patients, 97 had complete clinical
follow-up data. In these 97 patients a total of 121
thermocoagulation procedures were performed. A treatment
failure was defined as the presence of residual symptoms
persisting at least 2 weeks after thermocoagulation or
recurrence of symptoms resembling the initial symptoms
(pain and/or impaired function). Otherwise the treatment
was considered successful. In 76% (74/97) of these patients
treatment was successful, and in 24% (23/97) of patients
treatment failed after one thermocoagulation session. After
the initial thermocoagulation procedure (97 procedures),
22/23 treatment failure patients underwent a second
procedure. After this second procedure, two treatment failure
patients underwent an additional third thermocoagulation
session (one of these patients had recurrence of pain after
44 months) and two other patients had subsequent surgery.
Thus, a total of 121 thermocoagulation procedures was
performed in our patient group of 97 patients. The clinical
outcome, and definitions of diagnosis and outcome, have
been previously reported [1]. Anatomical location is listed
in Table 1. Of these 97 patients 51% (49/97) had osteoid
osteomas that were located extra-articularly and 49% (48/
97) intra-articularly. As to the location of the nidus within
bone, 65% (63/97) were cortical lesions, 23% (22/97)
endosteal lesions, 10% (10/97) were intramedullary
lesions and, in 2% (2/97), the location relative to the
cortex was not documented.
As part of the initial diagnostic work-up of osteoid
osteoma prior to thermocoagulation, 50/97 patients under-
went MRI, 59/97 patients underwent scintigraphy, 94/97
patients had radiographs performed and all patients under-
went CT scanning. After the radiological diagnosis was
made using plain radiography, CT, bone-scintigraphy and
MRI, CT-guided thermocoagulation was performed under
regional or general anaesthesia by a radiologist and/or
orthopaedic surgeon. The nidus was localised using incre-
mental CT (Tomoscan CXQ or LX; Philips Medical
Systems, Best, The Netherlands) or helical CT (Tomoscan
SR 7000 or AV E1; Philips Medical Systems).
Through a small skin incision, the centre of the lesion was
engaged, initially by using a Steinmann pin (Synthes,
Bettlach, Switzerland) during the first 40 procedures and
later by using a 14-gauge “Bonopty” needle system (Radi
Table 1 Anatomical location of osteoid osteomas in relation to the
treatment outcome (97 patients)
Location Successful treatment
(n=74)
Unsuccessful treatment
(n=23)
Femur 32 10
Tibia 13 1
Pelvis 6 2
Talus 4 1
Humerus 3 1
Ulna 3 1
Carpus 2 2
Metacarpal 2 1
Lumbar spine 2 1
Tarsal 2 1
Fibula 1 1
Cervical spine 1 1
Thoracic spine 1 0
Radius 1 0
Phalanx 1 0
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Medical Systems, Uppsala, Sweden) during the other 81
procedures. A biopsy (including cultures) was performed if
the clinical or radiographic appearance of the lesion was
atypical, in clinical practice mainly to rule out a Brodie’s
abscess. If a biopsy were needed, a needle system (Jamshidi;
Sherwood Medical, Belfast, Northern Ireland) was intro-
duced over the K wire of the Steinmann pin, or the
“Bonopty” needle system drill was removed and exchanged
for a 16-gauge biopsy needle. The position of the biopsy
needle was always monitored with CT. After the biopsy
needle had been removed, a dedicated cannula and,
subsequently, a radio-frequency probe [Sluijter-Metha can-
nula (20-gauge, length 145 mm, active tip 5 mm) for
radiofrequency probe, and a radiofrequency probe, both by
Radionics, Burlington, Massachusetts, USA] were intro-
duced through the penetration cannula.
The temperature at the tip of the thermocoagulation
electrode was monitored during the procedure. The lesions
were routinely heated to 90°C for 4 min (RFG-3C FF
lesion generator system, Radionics). After removal of the
needle system a CT scan was performed to assess where
the nidus had been hit and to check for possible
complications (e.g. haematoma). CT was able to determine
whether the nidus had been hit, since the needle track was
visualised after the procedure.
The mean clinical follow-up time after the only or last
thermocoagulation session was 41 months (range 5–
81 months).
CT follow-up
According to our clinical protocol, all patients should have
had clinical, CT and MRI follow-up at 3 months, 6 months,
12 months and 24 months after thermocoagulation. This
succeeded quite well for the clinical follow-up, but was
moderately successful for the CT follow-up and not very
successful for the MRI follow-up in these patients. The
reason was that the orthopaedic surgeon taking care of these
patients adhered quite strictly to the clinical portion but not
as strictly to the imaging portion of the follow-up protocol.
Eighty-nine percent (86/97) of patients were followed by
CT scan after undergoing thermocoagulation. This was after
the only thermocoagulation performed in successfully
treated patients and after the first or only thermocoagulation
procedure performed in treatment-failure patients (one of 23
failure patients had only one thermocoagulation session).
The mean CT follow-up time in these 86 patients was
14 months, range 2–32 months. If patients had more than
one follow-up CT scan performed after thermocoagulation,
then the last follow-up CT was used to evaluate bone
healing. For instance, if a patient had a follow-up CT at
6 months and 12 months, this patient was considered to
have a CT follow-up of 12 months, and this follow-up CT
12 months after thermocoagulation was used to evaluate
this bone healing. Thermocoagulation treatment was suc-
cessful in 63 patients (73%). In 27% (23/86) of patients
thermocoagulation did not result in a significant clinical
improvement. The 63 successfully treated patients had a
mean CT follow-up period of 15 months (range 6–32 months)
after the only thermocoagulation performed, and the 23
treatment failures had a mean CT follow-up time of 10months
(range 2–28 months) after the first or only thermocoagulation
performed (as mentioned before, one of 23 treatment-failure
patients had only one thermocoagulation procedure). The
mean clinical follow-up after the only or last thermocoagula-
tion for this group of 86 patients was 44 months (range 6–
81 months). In all patients the duration of the clinical follow-
up was at least as long as the duration of the CT follow-up.
CT follow-up examination was performed by incremental or
helical CT scanning. Incremental CT scanning was performed
with a 1–2mm slice-by-slice thickness (Tomoscan CXQor LX;
Philips Medical Systems). Helical CT scanning was performed
with a reconstructed slice thickness of 1 mm to 2 mm
(Tomoscan SR 7000, or AV E1; Philips Medical Systems).
A nidus was identified in all cases on a CT scan before
thermocoagulation. We compared follow-up CT scans with
the pre-treatment one, and classified changes into one of
five groups defined as: (1) complete ossification of the
nidus, (2) presence of a minimal nidus rest, (3) decrease in
size of the nidus, (4) unchanged size of the nidus, and (5)
changed configuration of the nidus, the latter most likely
being related to osteonecrosis after thermocoagulation.
MRI follow-up
According to our clinical protocol, all patients should have
had clinical, CT and MRI follow-up at 3 months, 6 months,
12 months and 24 months after thermocoagulation. As
mentioned before, this succeeded quite well for the clinical
follow-up, but was not as successful for the CT and MRI
follow-up in these patients. In addition, a relatively low
number of patients was included for MRI follow-up
compared with CT follow-up. This is explained by the fact
that progressively, during the period between June 1994
and April 2000, only patients with clinical suspicion of
treatment failure were selected for further MRI follow-up.
In 18 selected cases a gadolinium-enhanced dynamic
MRI was performed during follow-up (mean 12 months,
range 2–28 months) after thermocoagulation. This was after
the only thermocoagulation performed in successfully
treated patients and after the first or only thermocoagulation
procedure performed in treatment-failure patients (one of
five treatment-failure patients had only one thermocoagu-
lation session). As for CT scanning, if patients had
undergone more than one follow-up MRI, then the last
follow-up MRI was used to assess eventual changes in
Skeletal Radiol (2007) 36:813–821 815
“oedema-like” alterations of bone marrow and/or soft tissue
oedema and joint effusion as well as the delay time. The 13
successfully treated patients in this group had a mean MRI
follow-up period of 14 months (range 3–28 months) after
the only thermocoagulation, and the five treatment-failure
patients had a mean MRI follow-up period of 5 months
(range 2–10 months) after the first or only thermocoagula-
tion (as mentioned before, one of the five treatment-failure
patients included had only one thermocoagulation session).
The mean clinical follow-up time after the only or last
thermocoagulation in these 18 patients was 33 months
(range 6–81 months). In all patients the duration of the
clinical follow-up was at least as long as the duration of the
MRI follow-up.
A non-contrast coronal T1-turbo spin echo (TSE)
sequence (TR 550 ms, TE 12 ms), a transverse T1 gradient
echo sequence (T1 FFE) (TR 26 ms, TE 8.6 ms) and a
transverse T2 TSE sequence with fat suppression (TR
2,980 ms, TE 80 ms) were performed (Gyroscan ACS NT
15, Philips Medical Systems). For dynamic imaging, three
consecutive sections were taken through the lesion in the
transverse plane. A bolus injection of gadopentate dime-
glumine (Gd-DTPA) was administered (0.1 mmol/kilo-
gramme body weight, injected at 2 ml/s). A gradient echo
sequence was used for the dynamic sequence (T1 FFE, TR
9.5 ms, TE 3 ms) with a temporal resolution of 3 s per
image for a total of 120 s. All contrast images were
subtracted from the first non-enhanced gradient echo
image, and the time of enhancement of the osteoid osteoma
was related to the arterial enhancement (delay time). An
equilibrium contrast-enhanced series was obtained, consist-
ing of a T1 FFE with fat suppression (TR 45 ms, TE
8.6 ms). All sequences were performed with a 256 pixel×
256 pixel matrix. As for CT scanning, the nidus was
demonstrable on all MRI studies before thermocoagulation
was carried out.
Two parameters were assessed and compared on the
MRI studies performed before and after thermocoagulation:
(1) The presence of “oedema-like” changes of bone marrow
and/or soft tissue oedema or joint effusion; (2) the delay
time between the onset of arterial enhancement and
enhancement of the nidus, which was assessed by dynamic
MRI.
Analysis and statistical correlation
All CT scans and MR images were read and interpreted in
consensus by two musculoskeletal radiologists (G.V. and
another radiologist). The analysing radiologists were not
aware of the clinical data.
Prior to statistical analysis the five CT categories were
grouped into two main categories: (A). advanced bone
healing (complete ossification, and minimal residual nidus)
and (B) minimal or absent bone healing (decreased size,
and unchanged size of the nidus). Further statistical analysis
of bone healing on CT was carried out relative to the
treatment outcome (treatment success versus failure), the
length of CT follow-up, the location of the nidus within
bone (cortical versus an endosteal or an intramedullary
location) and the patient’s age. Because of the limited
number of patients in the group with thermonecrosis, this
group was not included in this statistical analysis.
The chi-square test and Fisher’s exact test were used to
evaluate differences in the fraction of patients with
advanced bone healing on CT between successfully treated
patients and patients with treatment failure. To test the
effect of the length of CT follow-up on bone healing, we
performed the same statistical tests on two subgroups with a
CT follow-up period of 2–12 months, and > 12 months,
respectively. To test for differences in bone healing relative
to the location of the nidus within bone (cortical versus an
endosteal or an intramedullary location), we used the chi-
square test, and to test for differences in age between
groups with different healing patterns we used the t-test. A
P value < 0.05 was considered statistically significant. A
software package (SPSS 12.0.1; SPPS, Chicago, Illinois,
USA) was used for statistical analysis. The number of
patients in the MRI follow-up was too small for an
adequate statistical analysis to be performed.
Results
Histology
A biopsy was taken in 58% (56/97) of patients. Histology
confirmed the presence of an osteoid osteoma in 36% (20/
Table 2 Distribution of the CT
healing pattern in successfully
and unsuccessfully treated
patients
aComplete ossification, a min-
imal nidus remnant or thermo-
necrosis was seen only after
successful treatment
CT healing pattern Successful treatment (n=63) Unsuccessful treatment (n=23)
Complete ossification 15 (24%) a 0
Minimal nidus remnant 14 (22%) a 0
Decreased diameter 16 (25%) 2 (9%)
Unchanged diameter 15 (24%) 21 (91%)
Thermonecrosis 3 (5%) a 0
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56) of patients. In the remainder a definite histological
diagnosis could not be made, because the amount of biopsy
material was too small. The diagnosis of osteoid osteoma
was confirmed histologically in 22% (19/86) of patients in
the CT follow-up group and in 22% (4/18) of patients in the
MRI follow-up group.
CT follow-up
Table 2 shows the distribution of the healing pattern on CT
in patients with successful and unsuccessful thermocoagu-
lation. Complete ossification, a minimal nidus remnant or
thermonecrosis was seen only in patients whose treatment
had been successful (Table 2, Figs. 1 and 2). Advanced
bone healing was more frequently (P<0.001) observed in
the successfully treated group (29/63 patients or 46%) than
in the treatment failure group (0 patients). Interestingly, all
15 patients (listed in Table 2) with complete ossification of
the nidus had osteoid osteomas that were located within the
cortex, and, in patients with an endosteal or an intra-
medullary location of the nidus, the highest degree of bone
healing observed was the presence of a minimal nidus rest,
but not complete ossification. This relationship was
statistically significant (P=0.03).
Table 3 illustrates the distribution of the healing pattern
for the two subgroups with 2–12 months or > 12 months of
CT follow-up. Advanced bone healing (the presence of
complete ossification and/or a minimal nidus rest) was
more frequently seen in the group with > 12 months’
follow-up (58% or 16/28 patients) than in the group with a
shorter follow-up period (37% or 13/35 patients), but this
difference in bone healing between the two groups was not
statistically significant (P=0.07).
No statistically significant relationship between bone
healing and age (in successfully and unsuccessfully treated
patients) was present, both in patients with a shorter (2–
12 months) and a longer (> 12 months) CT follow-up
period. The P value mentioned hereafter was observed in
the successfully treated group with a > 12 months CT
follow-up (P=0.1).
Fig. 1 Axial CT image of a nidus in the left hip region (arrow) in a
successfully treated patient before (a) and 11 months after (b)
thermocoagulation. Note complete ossification of the nidus after
(successful) thermocoagulation
Fig. 2 Axial CT image of a nidus in the left hip region (arrow) in a
treatment-failure patient before (a) and 12 months after (b) thermo-
coagulation. Note the absence of ossification within the nidus after
(unsuccessful) treatment
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MRI follow-up
Of the 18 patients who were followed with MRI, treatment
was successful in 13 (72%). Because of the limited number
of patients included in this MRI follow-up group, no
adequate statistical analysis could be performed, as has
been mentioned previously.
Table 4 shows the distribution of associated reactive bone
and soft tissue changes before and after thermocoagulation
on MRI in patients with successful and unsuccessful
thermocoagulation. All patients had shown “oedema-like”
changes of bone marrow and/or soft tissue edema or joint
effusion before thermocoagulation.
After treatment, three successfully treated patients
showed complete resolution of these oedematous or
“oedema-like” changes (Fig. 3). These three patients had
exhibited no joint effusion prior to thermocoagulation, and,
thus, no residual changes (“oedema-like” changes of bone
marrow, soft tissue oedema or joint effusion) were present
after thermocoagulation. A fourth patient in whom these
oedematous or “oedema-like” changes had completely
resolved had shown persistent joint effusion after successful
thermocoagulation. The other nine of 13 treatment suc-
cesses (69%) had residual “oedema-like” changes of bone
marrow, while all five treatment failures had residual
“oedema-like” changes of bone marrow (two of these
patients also had residual soft tissue oedema).
None of the patients with treatment failure showed
significant change in the pattern of “oedema-like”
changes of bone marrow or soft tissue oedema after
thermocoagulation (Fig. 4). Complete resolution was thus
not observed in this group.
Before thermocoagulation, joint effusion was seen in 44%
(8/18) of patients (Table 4). All lesions in these eight
patients had an intra-articular location (three were located
in the proximal femur, three in the talus and two in the
pelvis). This joint effusion persisted in all patients after
thermocoagulation, independent of treatment outcome (five
were treatment successes, the other three treatment failures).
Table 5 shows the delay time before and after
thermocoagulation on dynamic gadolinium-enhanced
MRI in patients with successful and unsuccessful
thermocoagulation. The results suggest that an increase
in delay time tends to be associated with successful
treatment, although the number of patients is small.
Before thermocoagulation, all osteoid osteomas showed a
rapid enhancement within 12 s after arterial enhancement.
In the successfully treated patient group eight of the 13
patients (62%) showed either slow (> 12 s delay time) or
no enhancement. In the treatment-failure group only one
of the five patients showed enhancement after 12 s.
Discussion
During CT follow-up there was a significant difference in
the appearance of the osteoid osteomas between patients
with successful and unsuccessful thermocoagulation. Com-
Table 3 CT healing pattern in successfully and unsuccessfully treated patients divided into two subgroups according to duration of follow-up
with CT scanning
CT healing Successful treatment (n=63) Unsuccessful treatment (n=23)
2–12 months (n=35) > 12 months (n=28) 2–12 months (n=18) > 12 months (n=5)
Complete ossification 7 (20%) a 8 (29%) a 0 0
Minimal nidus remnant 6 (17%) a 8 (29%) a 0 0
Decreased diameter 10 (29%) 6 (21%) 2 (11%) 0
Unchanged diameter 11 (31%) 4 (14%) 16 (89%) 5 (100%)
Thermonecrosis 1 (3%) 2 (7%) 0 0
aNo statistically significant (P=0.07) difference in bone healing was identified
Bone/soft tissue changes Successful
treatment (n=13)
Unsuccessful
treatment (n=5)
Before
TC
After
TC
Before
TC
After
TC
“Oedema-like” changes of bone marrow and soft tissue oedema 5/13 0/13 2/5 2/5
“Oedema-like” changes of bone marrow 8/13 9/13 3/5 3/5
Joint effusion 5/13 5/13 3/5 3/5
No “oedema-like” changes of bone marrow, no soft tissue
oedema and no joint effusion
0/13 3/13 0/5 0/5
Table 4 Bone and/or soft tis-
sue changes on MRI before
and after thermocoagulation
(TC) in successfully and un-
successfully treated patients
(because of the limited number
of patients in the MRI follow-
up group, statistical analysis
could not be performed)
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plete, or almost complete, ossification of the nidus was seen
only in patients (46% of good respondents) who were
successfully treated. CT findings, however, were of limited
value, because absence of this ossification pattern occurred
equally in patients with good and poor response to
treatment. Ossification occurs mainly within the first year
of treatment, as we did not find significant progression of
ossification after the first year.
These results are similar to the results published by
Lindner et al. [8], who found complete ossification of the
nidus in 53% (8/15) of successfully treated patients. In their
study the CT follow-up time was limited to 6 months, and
no results of unsuccessfully treated patients were reported.
Lindner et al. [8] also reported that osteoid osteomas
located within the cortex had a greater tendency to ossify
after successful thermocoagulation than those in other intra-
osseous locations. We made a similar observation after
successful thermocoagulation: complete ossification of the
nidus (present in 15 patients, Table 2) was exclusively seen
in patients with a cortical location of the nidus, and this
relationship was statistically significant (P=0.03).
A larger fraction of complete ossification of 75% (24/32
patients) was found in a study by Martel et al. [9] in
successfully treated patients after 12 months of follow-up
with CT scan. The higher percentage of complete ossifica-
tion in the latter study may be related to the thermocoagu-
lation technique that was applied. In our study a technique
was used with a non-cooled tip and an active tip length of
5 mm, identical to the technique that was used by Lindner
et al. [8]. From a theoretical perspective [4], we know that
this type of electrode creates an approximately 1 cm
spherical treatment zone of focal osteonecrosis. Martel et
al. [9] used a cooled electrode with an active tip of 10 mm.
The treatment zone in this technique is expected to be
larger, due to the longer size of the active tip, and the
infusion of saline, allowing greater heat transmission [4].
This larger treatment zone and thus larger area of thermal
injury may have caused more inflammation and secondary
ossification and might, therefore, have contributed to a
higher degree of ossification. Because of this larger
Fig. 4 Axial gadolinium-enhanced T1 FFE (TR 45 ms, TE 8.6 ms)
with fat suppression of the left hip before (a) and 3 months after (b)
unsuccessful thermocoagulation. Before thermocoagulation, marked
enhancement of the nidus (arrow) and the surrounding bone marrow
and soft tissues was identified, persisting at 3 months. On dynamic
gadolinium-enhanced MRI (not shown) rapid enhancement of the
nidus (with a delay time of 4 s) persisted after (unsuccessful)
thermocoagulation
Fig. 3 Axial gadolinium-enhanced T1 FFE (TR 45 ms, TE 8.6 ms)
with fat suppression of the left hip before (a) and 24 months after (b)
successful thermocoagulation. Before thermocoagulation, marked
enhancement of the nidus (arrow) and the surrounding bone marrow
and soft tissues was identified. No residual enhancement in and
around the nidus was seen after (successful) thermocoagulation. The
corresponding CT scan (not shown) 24 months after treatment
demonstrated a decreased diameter of the nidus, but no complete
ossification
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treatment zone, the use of a cooled tip is generally not
advocated for thermocoagulation of osteoid osteomas,
because of safety considerations. This applies especially
to osteoid osteomas of the spinal canal, because of the risk
of thermal injury to the spinal cord or adjacent neuro-
vascular structures [10, 11].
Other authors have also commented on the presence of
bone healing on CT scans after previous thermocoagulation.
Pinto et al. [4] mentioned that partial or complete
ossification of the nidus was to be expected over 2–
27 months, although little or no change in lesion appear-
ance was possible. In some cases the nidus could become
indistinguishable from surrounding bone, and reactive
changes in adjacent bone and periosteum tended to
diminish. Similar observations were made by Ghanem et
al. [12] in a series of 12 patients with osteoid osteomas that
were successfully treated with thermocoagulation. The
lowest percentage of complete ossification after successful
thermocoagulation of osteoid osteoma was reported by
Papagelopoulos et al. [13]. They treated 16 intra-articular
osteomas of the hip region with a 10 mm active but non-
cooled tip. At 12 months’ CT follow-up, 19 % (3/16) of
osteoid osteomas treated in their series demonstrated
complete ossification; the other lesions demonstrated partial
ossification (six patients) or no change (seven patients).
Martel et al. [9] reported that at a CT follow-up time of
12 months, all successfully treated patients without obvious
bone healing were over 16 years of age. In our study,
however, no statistically significant correlation between
bone healing on CT and the patient’s age was identified.
The presence of reactive changes in association with
osteoid osteoma has been described before [6]. Osteoid
osteomas produce a large amount of prostaglandins.
Elevations of the prostaglandin levels up to 100–1,000
times the normal level have been demonstrated within the
nidus of osteoid osteomas [6]. The production of such high
levels of prostaglandins generates inflammation of the peri-
tumoral soft tissue, causing reactive changes (synovitis and/
or effusion, and “oedema-like” changes of bone marrow as
well as soft tissue oedema) [6].
On MRI, all patients showed “oedema-like” changes
of bone marrow and/or soft tissue oedema before they
had undergone thermocoagulation or when the treat-
ment had failed (Table 4). However, residual “oedema-
like” changes of bone marrow were found in 69% (9/13)
of treatment successes. From a theoretical point of view,
one would expect a total absence of “oedema-like”
changes of bone marrow (or soft tissue oedema) after
successful thermocoagulation, reflecting the total heat-
induced destruction of the hormonally active nidus [6]. It
is unclear why these “oedema-like” changes of bone
marrow persist after successful thermocoagulation. It
may be that pain decreases because of the destruction
of nerve fibres in and around the nidus [14] after
successful thermocoagulation, while hormone production
is maintained. Other possible explanations include local
mechanical or degenerative changes [6], or reaction to
the procedure; in this latter case one would expect these
“oedema-like” changes of bone marrow to diminish gradually
or disappear after successful thermocoagulation. Further study
is required to determine the exact nature and evolution of
these residual “oedema-like” changes of bone marrow present
in successfully treated patients.
Joint effusion, present before thermocoagulation, persisted
in all of our patients after thermocoagulation, independent of
the treatment outcome. Consequently, because this joint
effusion persisted in all patients, it was not valuable in
differentiating treatment successes from treatment failures in
our series. It is likely that the underlying mechanism is the
same as for the persistent “oedema-like” changes of bone
marrow and soft tissue oedema described above.
The pattern of dynamic enhancement of non-treated
osteoid osteomas on MRI has been studied in detail by Liu
et al. [7]. They assessed the morphology or type of
enhancement curve, and found that nine of 11 patients
(82%) had peak enhancement of the osteoid osteoma in the
early arterial phase with early partial wash-out. In our study
we focused on the delay time (time between the onset of
arterial and nidus enhancement). Before treatment, all 18
osteoid osteomas showed enhancement within 12 s of the
onset of arterial enhancement (Table 5).
Although absence of enhancement was not observed in
the group with failed treatment, only 38% (5/13) of patients
with good response showed absence of enhancement
(Table 5). Only one patient with poor response had delayed
enhancement (> 12 s), while 62% (8/13) of successfully
Table 5 Comparison of the
MRI delay time (dynamic MRI
enhancement) in successfully
and unsuccessfully treated
patients, before and after ther-
mocoagulation (TC) (because
of the limited number of
patients in the MRI follow-up
group, statistical analysis could
not be performed)
MRI delay time Successful treatment (n=13) Unsuccessful treatment (n=5)
Before TC After TC Before TC After TC
0–6 seconds 8 3 4 3
7–12 seconds 5 2 1 1
13–20 seconds 0 2 0 1
>20 seconds 0 1 0 0
No enhancement 0 5 0 0
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treated patients showed no, or delayed, enhancement.
Slower enhancement may reflect the replacement of highly
vascular tissue by less vascularised or even avascular tissue
(such as scar tissue, fibrosis or bone) after successful
thermocoagulation. Although small numbers do not allow
statistical analysis, it seems that the low incidence of
change in enhancement indicates low potential for this
parameter to be useful in clinical practice.
Although the role of skeletal scintigraphy in the primary
diagnosis of osteoid osteoma has been reported in detail
previously [15], its use in the detection of residual or
recurrent osteoid osteoma after surgery or thermocoagula-
tion has not received much attention. Some case reports
[16, 17] have indicated, though, that scintigraphy may
reliably identify persistent or recurrent osteoid osteoma in a
post-operative setting.
Conclusion
Minimal or even absent bone healing of the nidus did not
necessarily indicate treatment failure, since it was also
observed in successfully treated patients. Therefore, based
upon CT findings solely, we could not differentiate between
treatment successes and failures. The value of MRI in
assessing the residual activity of the nidus after thermoco-
agulation was limited in this study. Clinical evaluation
remains essential in identifying patients that may benefit
from repeated thermocoagulation.
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